Omurzakov Argen, Rampam Sanjeev, Gonzalez Marcos R, Lozano-Calderon Santiago A
Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02144, USA.
Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02144, USA.
Radiother Oncol. 2025 Jan;202:110617. doi: 10.1016/j.radonc.2024.110617. Epub 2024 Nov 6.
Radiation-associated fractures (RAFs) are a challenging complication in oncologic patients, yet their incidence remains unknown and optimal management lacks consensus.
This review aimed to evaluate the incidence of RAFs in the trunk, pelvis, and extremities as well as non-union rates of surgical and non-surgical treatment.
A systematic review of PubMed and Embase databases was conducted. The study was registered on PROSPERO (ID: CRD42024513017). Studies were included if they reported RAFs in oncologic populations, had a sample size of at least five patients, and provided extractable data on RAF incidence or number. The STROBE checklist was utilized for evaluation of study quality. For eligible studies, quantitative analyses were conducted to determine weighted incidence of RAF and fracture non-union.
Thirty-five studies comprising 9,980 patients treated with radiation therapy were included. The weighted incidence of RAFs was calculated to be 6.5% across 8,061 patients. The weighted incidence of femoral RAF was 5.2%, while pelvic RAF incidence was 17.1%. Non-union rates after initial treatment varied from 4% to 100%, with an overall weighted incidence of 48%. Treatments included intramedullary nailing, fixation with screws/plate, prosthetic replacement, conservative treatment, and amputation, with varying success rates.
This review highlights RAFs as a significant complication of radiation therapy, with a weighted incidence of 6.5% and a non-union rate of 48%. Advanced radiation techniques have reduced RAF occurrences, but non-union remains a challenge, necessitating tailored treatment strategies. Further research is needed to optimize RAF management and improve patient outcomes.
放射性骨折(RAFs)是肿瘤患者中具有挑战性的并发症,但其发病率仍然未知,最佳治疗方案也缺乏共识。
本综述旨在评估躯干、骨盆和四肢放射性骨折的发病率以及手术和非手术治疗的不愈合率。
对PubMed和Embase数据库进行系统综述。该研究已在PROSPERO(ID:CRD42024513017)上注册。纳入的研究需报告肿瘤患者中的放射性骨折情况,样本量至少为5例患者,并提供关于放射性骨折发病率或数量的可提取数据。使用STROBE清单评估研究质量。对符合条件的研究进行定量分析,以确定放射性骨折和骨折不愈合的加权发病率。
纳入了35项研究,共9980例接受放射治疗的患者。8061例患者的放射性骨折加权发病率计算为6.5%。股骨放射性骨折的加权发病率为5.2%,而骨盆放射性骨折的发病率为17.1%。初始治疗后的不愈合率从4%到100%不等,总体加权发病率为48%。治疗方法包括髓内钉固定、螺钉/钢板固定、假体置换、保守治疗和截肢,成功率各不相同。
本综述强调放射性骨折是放射治疗的一种重要并发症,加权发病率为6.5%,不愈合率为48%。先进的放射技术减少了放射性骨折的发生,但不愈合仍然是一个挑战,需要制定个性化的治疗策略。需要进一步研究以优化放射性骨折的管理并改善患者预后。